PRONZATO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 2.806
AS - Asia 464
NA - Nord America 385
Continente sconosciuto - Info sul continente non disponibili 97
SA - Sud America 47
AF - Africa 8
OC - Oceania 1
Totale 3.808
Nazione #
IT - Italia 2.721
US - Stati Uniti d'America 355
SG - Singapore 161
CN - Cina 130
VN - Vietnam 87
BD - Bangladesh 38
FR - Francia 26
HK - Hong Kong 21
BR - Brasile 20
FI - Finlandia 16
AR - Argentina 10
DE - Germania 10
CA - Canada 9
JM - Giamaica 8
GB - Regno Unito 5
IN - India 5
JP - Giappone 5
NL - Olanda 5
CH - Svizzera 4
EC - Ecuador 4
BS - Bahamas 3
CO - Colombia 3
IE - Irlanda 3
IQ - Iraq 3
UA - Ucraina 3
VE - Venezuela 3
CL - Cile 2
ES - Italia 2
GT - Guatemala 2
KE - Kenya 2
MX - Messico 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SV - El Salvador 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
MA - Marocco 1
MR - Mauritania 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TR - Turchia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 3.711
Città #
Genova 1.145
Genoa 970
Rapallo 304
Vado Ligure 247
San Jose 98
Singapore 74
Ashburn 56
Beijing 24
Ho Chi Minh City 24
Lauterbourg 23
Hong Kong 18
Council Bluffs 17
Hanoi 17
Helsinki 15
Santa Clara 9
Milan 8
Frankfurt am Main 7
Chicago 6
Da Nang 6
Kingston 6
New York 6
Bordighera 5
Haiphong 5
Miami 5
Philadelphia 5
Tokyo 5
Boardman 4
Los Angeles 4
Buffalo 3
City of London 3
Dallas 3
Dublin 3
Modena 3
Nassau 3
Rome 3
Toronto 3
Woodstock 3
Amsterdam 2
Atlanta 2
Baghdad 2
Beinasco 2
Bellevue 2
Bình Phước 2
Bắc Giang 2
Can Tho 2
Columbus 2
Dayton 2
Detroit 2
Fort Lauderdale 2
Hampton 2
Herriman 2
Inglewood 2
Joinville 2
Kuala Lumpur 2
Kyiv 2
Las Vegas 2
Louisville 2
Lyndhurst 2
Managua 2
Mexico City 2
Nairobi 2
Naples 2
Parma 2
Phủ Lý 2
Riyadh 2
San Salvador 2
Santiago 2
Tianjin 2
Van Nuys 2
Verona 2
Washington 2
Waterbury 2
Wellington 2
Zurich 2
Abidjan 1
Agadir 1
Ahmedabad 1
Albuquerque 1
Amman 1
Andria 1
Angatuba 1
Aparecida de Goiânia 1
Arafat 1
Athens 1
Auberville 1
Avon 1
Azogues 1
Bang Lamung 1
Bangkok 1
Bari 1
Barquisimeto 1
Barra de Santa Rosa 1
Baturité 1
Belleville 1
Bellinzona 1
Belo Campo 1
Biên Hòa 1
Bogotá 1
Bom Jesus do Galho 1
Bowling Green 1
Totale 3.240
Nome #
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 189
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 179
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 177
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 171
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 170
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 169
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 165
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 154
Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives 152
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 152
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors 150
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 143
Medical approaches to preservation of fertility in female cancer patients 139
Economic Impact of Inter-Regional Health Mobility In The Oldest European Administrative Region: A Starting Point For Changing Organizational Model? 137
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: Extending endocrine sensitivity 131
Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors 130
Use in current clinical practice of 70-gene signature in early breast cancer 124
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group 122
Stevens-johnson syndrome after treatment with bendamustine 119
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients. 116
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. 114
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria 106
Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients 95
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 93
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors 88
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study 76
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 60
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study 56
The Impact of the Introduction of the Breast Unit Model in a Northwestern Italian Region 51
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy 43
End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center 28
Equità e sostenibilità dei farmaci innovativi nel carcinoma mammario metastatico: riflessioni sulla base dell’esperienza della Regione Liguria 9
Totale 3.808
Categoria #
all - tutte 14.131
article - articoli 14.131
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022217 0 10 9 27 3 31 4 48 22 29 7 27
2022/2023344 25 37 5 22 65 53 4 40 57 10 25 1
2023/2024180 6 23 3 28 16 9 29 8 7 10 7 34
2024/2025693 30 42 15 38 78 73 54 131 27 37 70 98
2025/20261.239 154 35 82 96 176 75 191 88 66 115 77 84
2026/2027137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 3.808